View Bill Status
View Bill Text
View Statement of Purpose / Fiscal Impact
S1371................................................by JUDICIARY AND RULES
MICELIUM - SPORES - Amends existing law to include spores or mycelium
capable of producing mushrooms that contain psilocybin or psilocin in
Schedule I controlled substances.
02/16 Senate intro - 1st rdg - to printing
02/17 Rpt prt - to Jud
02/26 Rpt out - rec d/p - to 2nd rdg
02/27 2nd rdg - to 3rd rdg
03/02 3rd rdg - PASSED - 34-0-1
AYES -- Andreason, Bailey, Brandt, Bunderson, Burkett, Burtenshaw,
Calabretta, Cameron, Compton(Duncan), Darrington, Davis, Gannon,
Geddes, Goedde, Hill, Ingram, Kennedy, Keough, Little, Lodge,
Malepeai, Marley, McKenzie, Noble(Anderson), Noh, Pearce, Richardson,
Schroeder, Sorensen, Stegner, Stennett, Sweet, Werk, Williams
NAYS -- None
Absent and excused -- McWilliams
Floor Sponsor - Hill
Title apvd - to House
03/03 House intro - 1st rdg - to Jud
03/10 Rpt out - rec d/p - to 2nd rdg
03/11 2nd rdg - to 3rd rdg
03/15 3rd rdg - PASSED - 61-0-9
AYES -- Andersen, Barraclough, Barrett, Bauer, Bayer, Black, Block,
Boe, Bolz, Bradford, Campbell, Cannon, Clark, Collins, Crow, Cuddy,
Deal, Denney, Douglas, Eberle, Edmunson, Ellsworth, Eskridge,
Field(18), Field(23), Gagner, Garrett, Harwood, Henbest, Jones,
Kellogg, Kulczyk, Langford, Langhorst, Martinez, McGeachin, McKague,
Meyer, Miller, Mitchell, Naccarato, Nielsen, Pasley-Stuart, Ring,
Ringo, Roberts, Robison, Rydalch, Sali, Sayler, Schaefer, Shepherd,
Shirley, Skippen, Smith(30), Smith(24), Smylie, Snodgrass, Trail,
Wills, Wood
NAYS -- None
Absent and excused -- Bedke, Bell, Jaquet, Lake, Moyle, Raybould,
Ridinger, Stevenson, Mr. Speaker
Floor Sponsor - Shirley
Title apvd - to Senate
03/16 To enrol
03/17 Rpt enrol - Pres signed
03/18 Sp signed
03/19 To Governor
03/24 Governor signed
Session Law Chapter 302
Effective: 07/01/04
]]]] LEGISLATURE OF THE STATE OF IDAHO ]]]]
Fifty-seventh Legislature Second Regular Session - 2004
IN THE SENATE
SENATE BILL NO. 1371
BY JUDICIARY AND RULES COMMITTEE
1 AN ACT
2 RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT; AMENDING SECTION 37-2705,
3 IDAHO CODE, TO INCLUDE SPORES OR MYCELIUM CAPABLE OF PRODUCING MUSHROOMS
4 THAT CONTAIN PSILOCYBIN OR PSILOCIN IN SCHEDULE I CONTROLLED SUBSTANCES
5 AND TO MAKE TECHNICAL CORRECTIONS.
6 Be It Enacted by the Legislature of the State of Idaho:
7 SECTION 1. That Section 37-2705, Idaho Code, be, and the same is hereby
8 amended to read as follows:
9 37-2705. SCHEDULE I. (a) The controlled substances listed in this section
10 are included in schedule I.
11 (b) Any of the following opiates, including their isomers, esters,
12 ethers, salts, and salts of isomers, esters, and ethers, unless specifically
13 excepted, whenever the existence of these isomers, esters, ethers and salts is
14 possible within the specific chemical designation:
15 (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-
16 4-piperidinyl]-N-phenylacetamide);
17 (2) Acetylmethadol;
18 (3) Allylprodine;
19 (4) Alphacetylmethadol (except levo-alphacetylmethadol also known as
20 levo-alpha-acetylmethadol, levomethadyl acetate or LAAM);
21 (5) Alphameprodine;
22 (6) Alphamethadol;
23 (7) Alpha-methylfentanyl;
24 (8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
25 piperidinyl]-N-phenylpropanamide);
26 (9) Benzethidine;
27 (10) Betacetylmethadol;
28 (11) Beta-hydroxyfentanyl
29 (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
30 (12) Beta-hydroxy-3-methylfentanyl (N-(1-(2-hydroxy-2-phenethyl)
31 -3-methyl-4-piperidinyl)-N-phenylpropanamide);
32 (13) Betameprodine;
33 (14) Betamethadol;
34 (15) Betaprodine;
35 (16) Clonitazene;
36 (17) Dextromoramide;
37 (18) Diampromide;
38 (19) Diethylthiambutene;
39 (20) Difenoxin;
40 (21) Dimenoxadol;
41 (22) Dimepheptanol;
42 (23) Dimethylthiambutene;
43 (24) Dioxaphetyl butyrate;
2
1 (25) Dipipanone;
2 (26) Ethylmethylthiambutene;
3 (27) Etonitazene;
4 (28) Etoxeridine;
5 (29) Furethidine;
6 (30) Hydroxypethidine;
7 (31) Ketobemidone;
8 (32) Levomoramide;
9 (33) Levophenacylmorphan;
10 (34) 3-Methylfentanyl;
11 (35) 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
12 piperidinyl]-N-phenylpropanamide);
13 (36) Morpheridine;
14 (37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
15 (38) Noracymethadol;
16 (39) Norlevorphanol;
17 (40) Normethadone;
18 (41) Norpipanone;
19 (42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
20 piperidinyl] propanamide);
21 (43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
22 (44) Phenadoxone;
23 (45) Phenampromide;
24 (46) Phenomorphan;
25 (47) Phenoperidine;
26 (48) Piritramide;
27 (49) Proheptazine;
28 (50) Properidine;
29 (51) Propiram;
30 (52) Racemoramide;
31 (53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
32 propanamide);
33 (54) Tilidine;
34 (55) Trimeperidine.
35 (c) Any of the following opium derivatives, their salts, isomers and
36 salts of isomers, unless specifically excepted, whenever the existence of
37 these salts, isomers and salts of isomers is possible within the specific
38 chemical designation:
39 (1) Acetorphine;
40 (2) Acetyldihydrocodeine;
41 (3) Benzylmorphine;
42 (4) Codeine methylbromide;
43 (5) Codeine-N-Oxide;
44 (6) Cyprenorphine;
45 (7) Desomorphine;
46 (8) Dihydromorphine;
47 (9) Drotebanol;
48 (10) Etorphine (except hydrochloride salt);
49 (11) Heroin;
50 (12) Hydromorphinol;
51 (13) Methyldesorphine;
52 (14) Methyldihydromorphine;
53 (15) Morphine methylbromide;
54 (16) Morphine methylsulfonate;
55 (17) Morphine-N-Oxide;
3
1 (18) Myrophine;
2 (19) Nicocodeine;
3 (20) Nicomorphine;
4 (21) Normorphine;
5 (22) Pholcodine;
6 (23) Thebacon.
7 (d) Hallucinogenic substances. Any material, compound, mixture or prepa-
8 ration which contains any quantity of the following hallucinogenic substances,
9 their salts, isomers and salts of isomers, unless specifically excepted, when-
10 ever the existence of these salts, isomers, and salts of isomers is possible
11 within the specific chemical designation (for purposes of this paragraph only,
12 the term "isomer" includes the optical, position and geometric isomers):
13 (1) 4-bromo-2,5-dimethoxy amphetamine;
14 (2) 2,5-dimethoxyamphetamine;
15 (3) 4-bromo-2,5-dimethoxyphenethylamine (some other names:
16 alpha-desmethyl DOB, 2C-B);
17 (4) 2,5-dimethoxy-4-ethylamphetamine (another name: DOET);
18 (5) 4-methoxyamphetamine (PMA);
19 (6) 5-methoxy-3,4-methylenedioxy-amphetamine;
20 (7) 4-methyl-2,5-dimethoxy-amphetamine (DOM, STP);
21 (8) 3,4-methylenedioxy amphetamine;
22 (9) 3,4-methylenedioxymethamphetamine (MDMA);
23 (10) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-
24 methyl-3,4 (methylenedioxy) phenethylamine, and N-ethyl MDA, MDE, MDEA);
25 (11) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-
26 alpha-methyl-3,4(methylenedioxy) phenethylamine, and N-hydroxy MDA);
27 (12) 3,4,5-trimethoxy amphetamine;
28 (13) Alpha-ethyltryptamine (some other names: etryptamine,
29 3-(2-aminobutyl) indole);
30 (14) Bufotenine;
31 (15) Diethyltryptamine (DET);
32 (16) Dimethyltryptamine (DMT);
33 (17) Ibogaine;
34 (18) Lysergic acid diethylamide;
35 (19) Marihuana;
36 (20) Mescaline;
37 (21) Parahexyl;
38 (22) Peyote;
39 (23) N-ethyl-3-piperidyl benzilate;
40 (24) N-methyl-3-piperidyl benzilate;
41 (25) Psilocybin;
42 (26) Psilocyn;
43 (27) Tetrahydrocannabinols. Synthetic equivalents of the substances con-
44 tained in the plant, or in the resinous extractives of Cannabis, sp.
45 and/or synthetic substances, derivatives, and their isomers with similar
46 chemical structure and pharmacological activity such as the following:
47 cis or trans tetrahydrocannabinol, and their optical isomers, exclud-
48 ing dronabinol in sesame oil and encapsulated in a soft gelatin capsule in
49 a drug product approved by the U.S. Food and Drug Administration.
50 cis or trans tetrahydrocannabinol, and their optical isomers.
51 cis or trans tetrahydrocannabinol, and its optical isomers. (Since
52 nomenclature of these substances is not internationally standardized, com-
53 pounds of these structures, regardless of numerical designation of atomic
54 positions are covered.)
55 (28) Ethylamine analog of phencyclidine (N-ethyl-1-phenylcyclohexylamine
4
1 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl) ethylamine,
2 cyclohexamine, PCE;
3 (29) Pyrrolidine analog of phencyclidine: 1-(phenylcyclohexyl)
4 -pyrrolidine, PCPy, PHP;
5 (30) Thiophene analog of phencyclidine
6 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine,
7 TPCP, TCP;
8 (31) 1-[1-(2-thienyl) cyclohexyl] pyrrolidine another name: TCPy;
9 (32) Spores or mycelium capable of producing mushrooms that contain
10 psilocybin or psilocin.
11 (e) Unless specifically excepted or unless listed in another schedule,
12 any material, compound, mixture or preparation which contains any quantity of
13 the following substances having a depressant effect on the central nervous
14 system, including its salts, isomers, and salts of isomers whenever the exis-
15 tence of such salts, isomers, and salts of isomers is possible within the spe-
16 cific chemical designation:
17 (1) Gamma hydroxybutyric acid (some other names include GHB; gamma-
18 hydroxybutyrate, 4-hydroxybutyrate; 4-hyroxybutanoic acid; sodium oxybate;
19 sodium oxybutyrate);
20 (2) Flunitrazepam (also known as "R2", "Rohypnol");
21 (3) Mecloqualone;
22 (4) Methaqualone.
23 (f) Stimulants. Unless specifically excepted or unless listed in another
24 schedule, any material, compound, mixture, or preparation which contains any
25 quantity of the following substances having a stimulant effect on the central
26 nervous system, including its salts, isomers, and salts of isomers:
27 (1) Aminorex (some other names: aminoxaphen,
28 2-amino-5-phenyl-2-oxazoline, or 4,5-dihydro-5-phenyl-2-oxazolamine);
29 (2) Cathinone (some other names: alpha-aminopropiophenone,
30 2-aminopropiophenone and norephedrone);
31 (3) Fenethylline;
32 (4) Methcathinone (some other names: 2-(methyl-amino)-propiophenone,
33 alpha-(methylamino)-propiophenone, N-methylcathinone, AL-464, AL-422,
34 AL-463 and UR1423);
35 (5) (t)cis-4-methylaminorex
36 [(+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine];
37 (6) N-ethylamphetamine;
38 (7) N,N-dimethylamphetamine (also known as: N,N-alpha-trimethyl-
39 benzeneethanamine).
40 (g) Temporary listing of substances subject to emergency scheduling. Any
41 material, compound, mixture or preparation which contains any quantity of the
42 following substances:
43 (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its
44 optical isomers, salts and salts of isomers.
45 (2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
46 (thenylfentanyl), its optical isomers, salts and salts of isomers.
47 (3) 4-methylaminorex (also known as 2-amino-4-methyl-
48 5-phenyl-2-oxazoline).
STATEMENT OF PURPOSE
RS 13869
Psilocybin and psilocin are Schedule I Controlled Substances.
This legislation adds spores or mycelium capable of producing
mushrooms that contain psilocybin or psilocin to the list of
Schedule I Controlled Substances.
FISCAL IMPACT
None.
Contact
Name: Senator Brent Hill
Phone: 208-332-1347
STATEMENT OF PURPOSE/FISCAL NOTE S 1371